Cinacalcet (Sensipar ® /Mimpara ®, Amgen Inc., Thousand Oaks, CA), the first-in-class calcimimetic agent approved for treatment of secondary hyperparathyroidism in dialysis patients, is ...

Fluorescence imaging is the visualization of fluorescent dyes or proteins as labels for molecular processes or structures. It enables a wide range of experimental observations including the ...

Even more period-appropriate weapons are yours to play with as you work with the French Resistance to liberate the country, and, of course, the X-Ray cam is back to allow you to revel in the ...

The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...

An observational, multicenter, real-world study conducted at 12 screening sites in Germany has reported a 17.6% higher cancer detection rate among women aged 50–69 who received AI-supported ...

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...

Gerdau S/A Ord-2.55% R$34.27B ...